Nanosphere, Inc.
4088 Commercial Avenue
Northbrook,
IL 60062
United States - Map
Phone: 847-400-9000
Fax: 847-400-9199
Web Site: http://www.nanosphere.us
| Nanosphere, Inc. develops, manufactures, and markets a molecular diagnostics platform, the Verigene System that enables genomic and protein testing on a single platform. Its proprietary nanoparticle technology enables earlier detection of diseases through ultra-sensitive protein detection; and provides the ability to run multiple tests at the same time on the same sample. The company is developing diagnostic tests for markers, which reveal the existence of various medical conditions, including cancer, cardiovascular, respiratory, autoimmune, neurodegenerative, and infectious diseases, as well as for pharmacogenomics. It also involves in developing and commercializing genomic and protein assays, including hyper-coagulation, warfarin metabolism, cystic fibrosis, respiratory virus panel, hemochromatosis, blood infection panel, human papillomavirus, cardiac troponin I, prostate specific antigen, and biomarker validation; and RF & Anti-CCP, a test for the earlier diagnosis of rheumatoid arthritis. Nanosphere has a collaborative agreement with Eli Lilly & Co. to employ pharmacogenetic assays in drug development initiatives. The company was founded in 1998 and is headquartered in Northbrook, Illinois. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. William P. Moffitt III, 62
Chief Exec. Officer, Pres |
$
569.00K |
$
0 | Dr. Chad A. Mirkin Ph.d., 45
Co Founder, Director and Member of Scientific Advisory Board |
N/A
| N/A | Mr. J. Roger Moody Jr., 41
Chief Financial Officer, Principal Accounting Officer, VP of Fin. & Admin., Sec. and Treasurer |
$
329.00K |
$
0 | Mr. Michael K. McGarrity , 46
Chief Marketing Officer and VP of Sales & Marketing |
$
329.00K |
$
0 | Mr. Winton G. Gibbons , 46
Sr. VP of Bus. Devel. |
$
314.00K |
$
0 |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.67% Nasdaq 
0.01 (0.16%) 
Profile
